Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Egendal

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|March 20, 2025
On the Relation Between Linear Autoencoders and Non-Negative Matrix Factorization for Mutational Signature ExtractionIda Egendal, Rasmus Froberg Brøndum, Marta Pelizzola, et al.
BMC Cancer|June 16, 2023
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)Louise Skau Rasmussen, Stine B Winther, Inna M Chen, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|March 20, 2025
On the Relation Between Linear Autoencoders and Non-Negative Matrix Factorization for Mutational Signature ExtractionIda Egendal, Rasmus Froberg Brøndum, Marta Pelizzola, et al.
BMC Cancer|June 16, 2023
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)Louise Skau Rasmussen, Stine B Winther, Inna M Chen, et al.
Pageof 1